Calendar year second quarter organic growth continued at a strong pace for major US publicly held instrument and laboratory product companies. However, currency headwinds, as well as weakness in industrial markets and Japan expunged organic growth. Currency reduced gains by about 7%, resulting in roughly flat second quarter average sales growth. Pharmaceutical and biotechnology markets […]
The US Bureau of Economic Analysis (BEA) released this month the latest figures for US companies’ R&D domestic spending and R&D spending by foreign-owned affiliates. The report shows dramatic shifts in annual R&D spending by both segments in recent years among industries that are major purchasers of analytical instruments. The data provide quantitative information on […]
The consolidation of drug distributors is resulting in mergers among manufacturers of generic drugs. In the US, four companies buy the majority of generics, and generic-drug firms could merge to increase their abilities to negotiate with distributors. Merging may also help the companies face the costs of heightened examination of the industry by US regulators […]
In 2014, the top 50 chemical companies’ sales totaled $961.3 billion, declining less than 1% from last year’s $965.1 billion. The loss was in line with falling chemical prices resulting from the drop in oil prices. In general, specialty chemical companies fared better than petrochemical firms. The combined operating income of the 44 public companies […]
Slow Growth for Bruker Despite higher-than-expected sales and sequential growth, Bruker’s Scientific Instruments (BSI) second quarter sales grew just 0.6% to $366.2 million to account for 92% of revenues (see page 12). Bruker BioSpin sales fell in the mid-single digits due to lower demand in Preclinical Imaging, which accounts for 20% of Group sales. The […]
Susteren, Netherlands 7/13/15—Research reagent firm Nordic-MUbio has acquired the antibody and protein assets of US-based Brighter Ideas for an undisclosed amount. The acquisition includes the only source of antibodies against native Aequorea victoria green fluorescent protein (GFP). “Citations of GFP remain at a very high level since it was first described in 1994 as it […]
West Chester, PA 8/4/15—Chiral Technologies, a DAICEL company and provider of enantioselective chromatography, has acquired the assets of Diffinity Genomics for an undisclosed amount. Diffinity Genomics supplies the RapidTip technology for single-step rapid purification of amplified DNA fragments. ”The innovative, patented purification technology from Diffinity was a perfect choice for our expansion in the bio-separation/purification […]
Jena, Germany 8/7/15—Measurement firm Endress+Hauser has announced that following a voluntary tender offer beginning July 9, it has acquired 95% of Analytik Jena (see IBO 9/30/13) at a price of €14 ($15 = €0.91 = $1) per share, as previously planned. “Our aim is still the complete takeover of Analytik Jena,” stated Dr. Heiner Zehntner, […]
Hamburg, Germany 8/3/15—Life science company Eppendorf has named Thomas Bachmann as CEO (see IBO 2/15/15), effective August 1. Previously, he served as president of Bruker BioSpin (see IBO 9/30/13) and has been a member of Eppendorf’s Supervisory Board since 2013. “He has demonstrated his expertise and his strategic foresight in many ways during more than […]
Brno, Czech Republic 8/3/15—SEM provider Tescan Orsay has acquired AppFive, a US-based charged-particle optics application software and technique development company. Financial details were not disclosed. Tescan stated that the acquisition will allow it to develop solutions in collaboration with the semiconductor and research markets. “By extending our R&D capacities in mutual synergy with AppFive, we […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
